Insider Transactions Reported by 20 Insiders of Altimmune, Inc.

Symbol
ALT on Nasdaq
Location
Gaithersburg, MD

Insiders trading volume in the past year

Altimmune, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vipin K. Garg President and CEO, Director $2,357,744 30 Jan 2025
Matthew Scott Harris Chief Medical Officer $457,912 31 Jul 2025
Richard I. Eisenstadt Chief Financial Officer $441,118 30 Jan 2024
David Drutz Director $382,005 19 Aug 2024
M. Scot Roberts Chief Scientific Officer $232,567 31 Jul 2025
William Michael Brown Chief Financial Officer $199,361 31 Jul 2021
Raymond M. Jordt Chief Business Officer $113,887 31 Jul 2025
GREGORY WEAVER Chief Financial Officer $98,773 +$51,996 +111% 11 Nov 2025
Andrew Shutterly Acting Chief Financial Officer $61,523 31 Jul 2024
Jerome Benedict Durso Director $51,568 +$51,569 22 Dec 2025
JOHN GILL Director $51,249 +$51,250 23 Dec 2025
Catherine A. Sohn Director $5,785 +$5,785 25 Sep 2025
Diane Jorkasky Director $2,002 +$2,003 29 Dec 2025
MITCHEL SAYARE Director 25 Sep 2025
Linda M. Richardson Chief Commercial Officer 16 Sep 2025
Teri Lawver Director 25 Sep 2025
Wayne Pisano Director 25 Sep 2025
Klaus Schafer Director 25 Sep 2025
Philip Hodges Director 25 Sep 2025
Christophe Arbet-Engels Chief Medical Officer 01 Oct 2025

Recent Insider Transactions by Companies or Individuals for Altimmune, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.